Studies Wish List

Are these the most important studies globally to run in 2025 that could add 30 years to your healthspan?

3 Human Rejuvenation Studies

Seeking participants, funders & researchers

Human Study 1

Zolman Clocks for All 82 Organ Types

$1.1M/USD
  • Continue building Zolman Clocks to measure age accurately across all 82 organs
  • Fund researchers to join Dr Zolman's team
  • Develop aging clocks per organ using existing & new datasets
  • Includes MRI and ultrasound data analysis programmers
Fund This Study
Human Study 2

Combination Rejuvenation Gene Therapies

Contact for details
  • Translate gene therapies that have worked in mice
  • The Terminator Gene Therapy: all 7 known rejuvenation gene therapies
  • 1-6 combo gene therapies tested across multiple delivery routes
  • Goal: increase human healthspan
Fund This Study
Human Study 3

Remove Zombie White Blood Cells

Contact for details
  • Remove or kill senescent CD4/CD8 T cells from blood
  • Via filtration or accurate selective killing
  • Targets a major driver of immune aging
  • Translational pipeline from existing research
Fund This Study

3 Mouse Lifespan Studies to Fund

Seeking funders & researchers

Mouse Study 1

Dr Aubrey de Grey's Mouse Rejuvenation World-Record Attempt

$20M/USD
  • Combo rejuvenation therapy studies in older mice
  • Identify which therapies stack benefits
  • Aim: break the mouse lifespan world record
  • 4 studies × $5M each
  • Partner: levf.org
Fund This Study
Mouse Study 2

Combination Gene Therapies World-Record

$5M/USD
  • 1-6 combo gene therapies in older mice
  • Various routes of administration tested
  • The Terminator Gene Therapy: all 7 known rejuvenation gene therapies
  • Goal: extend mouse lifespan beyond current record
Fund This Study
Mouse Study 3

Remove Zombie White Blood Cells in Mice

Funding sought: Pending
  • Remove or kill senescent immune cells in mice
  • Via filtration or accurate selective killing
  • Test rejuvenation effect on healthspan
  • Pre-clinical foundation for human Study 3
Fund This Study